1046815-98-8 Usage
Description
Propan-2-yl 4-(cyanoMethyl)piperidine-1-carboxylate is a chemical compound with the molecular formula C14H22N2O2. It is an ester formed from propan-2-yl alcohol and 4-(cyanoMethyl)piperidine-1-carboxylic acid. propan-2-yl 4-(cyanoMethyl)piperidine-1-carboxylate is characterized by its potential interactions with the central nervous system, making it a promising candidate for pharmaceutical development, particularly in the area of neurological disorders. However, due to its potential toxic or harmful effects, it is crucial to handle and use this chemical with appropriate caution.
Uses
Used in Pharmaceutical Industry:
Propan-2-yl 4-(cyanoMethyl)piperidine-1-carboxylate is used as a precursor in the synthesis of pharmaceuticals and research chemicals. Its role in this industry is pivotal for the development of new drugs, especially those targeting neurological disorders, due to its ability to interact with the central nervous system.
Used in Research and Development:
In the realm of scientific research, propan-2-yl 4-(cyanoMethyl)piperidine-1-carboxylate serves as a valuable component in the creation of research chemicals. This allows scientists to explore its properties and potential applications further, contributing to the advancement of medical science and drug discovery.
Check Digit Verification of cas no
The CAS Registry Mumber 1046815-98-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,4,6,8,1 and 5 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1046815-98:
(9*1)+(8*0)+(7*4)+(6*6)+(5*8)+(4*1)+(3*5)+(2*9)+(1*8)=158
158 % 10 = 8
So 1046815-98-8 is a valid CAS Registry Number.
1046815-98-8Relevant articles and documents
COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY
-
Page/Page column 71-72, (2008/12/08)
The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of GPR119.
